Oxidative stress by inorganic nanoparticles

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 8, Issue 3, 2016, Pages 414-438

  Tee, Jie Kai ^a,b   Ong, Choon Nam ^a   Bay, Boon Huat ^a   Ho, Han Kiat ^a,b   Leong, David Tai ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; CELL DEATH; METALLIC COMPOUNDS; METALS; NANOPARTICLES; OXIDANTS;

BIOLOGICAL EFFECTS; EXOGENOUS SOURCE; HEALTH CONSEQUENCES; HUMAN EXPOSURES; INORGANIC NANOPARTICLE; METALLIC OXIDES; OPTICAL SENSITIVITY; PHYSIO-CHEMICAL PROPERTIES;

OXIDATIVE STRESS;

CYTOCHROME; INORGANIC COMPOUND; LIPOXYGENASE; MITOCHONDRIAL ENZYME; NANOPARTICLE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OXIDIZING AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; UNCLASSIFIED DRUG; METAL NANOPARTICLE;

ANTIOXIDANT ACTIVITY; CELL DEATH; CELL GROWTH; CELL SURFACE; CONDUCTANCE; DENDRITIC CELL; DIABETES MELLITUS; EPITHELIUM CELL; FIBROBLAST; HUMAN; INFLAMMATION; LIPID METABOLISM; NEOPLASM; NERVE DEGENERATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PEROXISOME; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIA; THYROID CELL; VASCULAR DISEASE; ANIMAL; CELL LINE; CELL PROLIFERATION; DRUG EFFECTS; MEDICAL RESEARCH; NANOMEDICINE;

ANIMALS; BIOMEDICAL RESEARCH; CELL DEATH; CELL LINE; CELL PROLIFERATION; HUMANS; METAL NANOPARTICLES; NANOMEDICINE; OXIDATIVE STRESS;

EID: 84941309238     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1374     Document Type: Review

References (177)

1. Fridovich I. Oxidative stress. In: eLS. Chichester: John Wiley & Sons Ltd; 2014. doi:10.1002/9780470015902.a0001376.pub3. Available at: http://www.els.net.
2. Setyawati MI, Tay CY, Chia SL, Goh SL, Fang W, Neo MJ, Chong HC, Tan SM, Loo SC, Ng KW, et al. Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin. Nat Commun 2013, 4:1673.
3. Monteiro-Riviere NA. Chapter 6: Nanoparticle penetration and biological interactions with skin. In: Nasir A, Friedman A, Wang S, eds. Nanotechnology in Dermatology. New York: Springer; 2013, 51-61.
4. Doane TL, Burda C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem Soc Rev 2012, 41:2885-2911.
5. Arvizo RR, Bhattacharyya S, Kudgus RA, Giri K, Bhattacharya R, Mukherjee P. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev 2012, 41:2943-2970.
6. Sasidharan A, Monteiro-Riviere NA. Biomedical applications of gold nanomaterials: opportunities and challenges. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2015. doi: 10.1002/wnan.1341 (Online Version of Record before inclusion in an issue).
7. Thurn KT, Brown E, Wu A, Vogt S, Lai B, Maser J, Paunesku T, Woloschak GE. Nanoparticles for applications in cellular imaging. Nanoscale Res Lett 2007, 2:430-441.
8. Jia F, Liu X, Li L, Mallapragada S, Narasimhan B, Wang Q. Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents. J Control Release 2013, 172:1020-1034.
9. Ikoba U, Peng H, Li H, Miller C, Yu C, Wang Q. Nanocarriers in therapy of infectious and inflammatory diseases. Nanoscale 2015, 7:4291-4305.
10. Gaharwar AK, Peppas NA, Khademhosseini A. Nanocomposite hydrogels for biomedical applications. Biotechnol Bioeng 2014, 111:441-453.
11. Zhan Y, Zeng W, Jiang G, Wang Q, Shi X, Zhou Z, Deng H, Du Y. Construction of lysozyme exfoliated rectorite-based electrospun nanofibrous membranes for bacterial inhibition. J Appl Polym Sci 2015, 132:41496.
12. Ramesh GV, Kodiyath R, Tanabe T, Manikandan M, Fujita T, Matsumoto F, Ishihara S, Ueda S, Yamashita Y, Ariga K, et al. NbPt3 intermetallic nanoparticles: highly stable and CO-tolerant electrocatalyst for fuel oxidation. ChemElectroChem 2014, 1:728-732.
13. Alam S, Anand C, Ariga K, Mori T, Vinu A. Unusual magnetic properties of size-controlled iron oxide nanoparticles grown in a nanoporous matrix with tunable pores. Angew Chem Int Ed 2009, 48:7358-7361.
14. Giovanni M, Tay CY, Setyawati MI, Xie J, Ong CN, Fan R, Yue J, Zhang L, Leong DT. Toxicity profiling of water contextual zinc oxide, silver, and titanium dioxide nanoparticles in human oral and gastrointestinal cell systems. Environ Toxicol 2014. doi: 10.1002/tox.22015 (Online Version of Record before inclusion in an issue).
15. Zhao Y, Ng KW. Nanotoxicology in the skin: how deep is the issue? Nano LIFE 2014, 4:1440004.
16. Imam SZ, Lantz-McPeak SM, Cuevas E, Rosas-Hernandez H, Liachenko S, Zhang Y, Sarkar S, Ramu J, Robinson BL, Jones Y, et al. Iron oxide nanoparticles induce dopaminergic damage: in vitro pathways and in vivo imaging reveals mechanism of neuronal damage. Mol Neurobiol 2015. doi: 10.1007/s12035-015-9259-2 (Epub ahead of print).
17. Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
18. Pengyang W, Xin W, Liming W, Xiaoyang H, Wei L, Chunying C. Interaction of gold nanoparticles with proteins and cells. Sci Technol Adv Mater 2015, 16:034610.
19. Giovanni M, Yue J, Zhang L, Xie J, Ong CN, Leong DT. Pro-inflammatory responses of RAW264.7 macrophages when treated with ultralow concentrations of silver, titanium dioxide, and zinc oxide nanoparticles. J Hazard Mater 2015, 297:146-152.
20. Lin Z, Monteiro-Riviere NA, Riviere JE. Pharmacokinetics of metallic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2015, 7:189-217.
21. Balasubramanian SK, Poh KW, Ong CN, Kreyling WG, Ong WY, Yu LE. The effect of primary particle size on biodistribution of inhaled gold nano-agglomerates. Biomaterials 2013, 34:5439-5452.
22. Chew WS, Poh KW, Siddiqi NJ, Alhomida AS, Yu LE, Ong WY. Short- and long-term changes in blood miRNA levels after nanogold injection in rats-potential biomarkers of nanoparticle exposure. Biomarkers 2012, 17:750-757.
23. Zhang XD, Luo Z, Chen J, Wang H, Song SS, Shen X, Long W, Sun YM, Fan S, Zheng K, et al. Storage of gold nanoclusters in muscle leads to their biphasic in vivo clearance. Small 2015, 11:1683-1690.
24. Zhang XD, Luo Z, Chen J, Shen X, Song S, Sun Y, Fan S, Fan F, Leong DT, Xie J. Ultrasmall Au(10-12)(SG)(10-12) nanomolecules for high tumor specificity and cancer radiotherapy. Adv Mater 2014, 26:4565-4568.
25. Zheng K, Yuan X, Goswami N, Zhang Q, Xie J. Recent advances in the synthesis, characterization, and biomedical applications of ultrasmall thiolated silver nanoclusters. RSC Adv 2014, 4:60581-60596.
26. Goswami N, Zheng K, Xie J. Bio-NCs-the marriage of ultrasmall metal nanoclusters with biomolecules. Nanoscale 2014, 6:13328-13347.
27. Jones DP. Redefining oxidative stress. Antioxid Redox Signal 2006, 8:1865-1879.
28. Bast A, Haenen GRMM, Doelman CJA. Oxidants and antioxidants: state of the art. Am J Med 1991, 91:S2-S13.
29. Harman D. Origin and evolution of the free radical theory of aging: a brief personal history, 1954-2009. Biogerontology 2009, 10:773-781.
30. Gruber J, Schaffer S, Halliwell B. The mitochondrial free radical theory of ageing-where do we stand? Front Biosci 2008, 13:6554-6579.
31. Kepp O, Galluzzi L, Kroemer G. Mitochondrial control of the NLRP3 inflammasome. Nat Immunol 2011, 12:199-200.
32. Sorbara MT, Girardin SE. Mitochondrial ROS fuel the inflammasome. Cell Res 2011, 21:558-560.
33. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002, 27:339-344.
34. Kawanishi S, Oikawa S. Mechanism of telomere shortening by oxidative stress. Ann N Y Acad Sci 2004, 1019:278-284.
35. Bhabra G, Sood A, Fisher B, Cartwright L, Saunders M, Evans WH, Surprenant A, Lopez-Castejon G, Mann S, Davis SA, et al. Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotechnol 2009, 4:876-883.
36. Mahmoudi M, Azadmanesh K, Shokrgozar MA, Journeay WS, Laurent S. Effect of nanoparticles on the cell life cycle. Chem Rev 2011, 111:3407-3432.
37. Stern S, Adiseshaiah P, Crist R. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol 2012, 9:20.
38. 2) nanoparticles. Toxicol In Vitro 2010, 24:1002-1008.
39. Bancos S, Stevens DL, Tyner KM. Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro. Int J Nanomedicine 2015, 10:183-206.
40. Nathan C, Cunningham-Bussel A. Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat Rev Immunol 2013, 13:349-361.
41. Bell IR, Ives JA, Jonas WB. Nonlinear effects of nanoparticles: biological variability from hormetic doses, small particle sizes, and dynamic adaptive interactions. Dose Response 2014, 12:202-232.
42. Ushio-Fukai M. Localizing NADPH oxidase-derived ROS. Sci STKE 2006, 2006:re8.
43. Landry WD, Cotter TG. ROS signalling, NADPH oxidases and cancer. Biochem Soc Trans 2014, 42:934-938.
44. Kovac S, Angelova PR, Holmström KM, Zhang Y, Dinkova-Kostova AT, Abramov AY. Nrf2 regulates ROS production by mitochondria and NADPH oxidase. Biochim Biophys Acta 2015, 1850:794-801.
45. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007, 47:89-116.
46. Lewis DFV. Oxidative stress: the role of cytochromes P450 in oxygen activation. J Chem Technol Biotechnol 2002, 77:1095-1100.
47. Robertson G, Leclercq I, Farrell GC. Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 2001, 281:G1135-G1139.
48. Ekström G, Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 1989, 38:1313-1319.
49. Dixon RAF, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, Gillard JW, Miller DK. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 1990, 343:282-284.
50. Domenico P, Joshi Y. The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer's disease phenotype. Front Cell Neurosci 2015, 8:436.
51. Nordgren M, Fransen M. Peroxisomal metabolism and oxidative stress. Biochimie 2014, 98:56-62.
52. Terlecky SR, Terlecky LJ, Giordano CR. Peroxisomes, oxidative stress, and inflammation. World J Biol Chem 2012, 3:93-97.
53. Wang B, Van Veldhoven PP, Brees C, Rubio N, Nordgren M, Apanasets O, Kunze M, Baes M, Agostinis P, Fransen M. Mitochondria are targets for peroxisome-derived oxidative stress in cultured mammalian cells. Free Radic Biol Med 2013, 65:882-894.
54. Liu Y, Fiskum G, Schubert D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem 2002, 80:780-787.
55. St-Pierre J, Buckingham JA, Roebuck SJ, Brand MD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 2002, 277:44784-44790.
56. Indo HP, Davidson M, Yen H-C, Suenaga S, Tomita K, Nishii T, Higuchi M, Koga Y, Ozawa T, Majima HJ. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion 2007, 7:106-118.
57. Schulz E, Wenzel P, Munzel T, Daiber A. Mitochondrial redox signaling: interaction of mitochondrial reactive oxygen species with other sources of oxidative stress. Antioxid Redox Signal 2014, 20:308-324.
58. Lavieri R, Piccioli P, Carta S, Delfino L, Castellani P, Rubartelli A. TLR costimulation causes oxidative stress with unbalance of proinflammatory and anti-inflammatory cytokine production. J Immunol 2014, 192:5373-5381.
59. Ameziane-El-Hassani R, Talbot M, de Souza Dos Santos MC, Al Ghuzlan A, Hartl D, Bidart J-M, De Deken X, Miot F, Diallo I, de Vathaire F, et al. NADPH oxidase DUOX1 promotes long-term persistence of oxidative stress after an exposure to irradiation. Proc Natl Acad Sci USA 2015, 112:5051-5056.
60. Zahlten J, Kim YJ, Doehn JM, Pribyl T, Hocke AC, Garcia P, Hammerschmidt S, Suttorp N, Hippenstiel S, Hubner RH. Streptococcus pneumoniae-induced oxidative stress in lung epithelial cells depends on pneumococcal autolysis and is reversible by resveratrol. J Infect Dis 2015, 211:1822-1830.
61. Yang W, Yu M, Fu J, Bao W, Wang D, Hao L, Yao P, Nüssler AK, Yan H, Liu L. Deoxynivalenol induced oxidative stress and genotoxicity in human peripheral blood lymphocytes. Food Chem Toxicol 2014, 64:383-396.
62. Sharma V, Anderson D, Dhawan A. Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2). Apoptosis 2012, 17:852-870.
63. Sharma V, Singh P, Pandey AK, Dhawan A. Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles. Mutat Res 2012, 745:84-91.
64. Kovvuru P, Mancilla PE, Shirode AB, Murray TM, Begley TJ, Reliene R. Oral ingestion of silver nanoparticles induces genomic instability and DNA damage in multiple tissues. Nanotoxicology 2015, 9:162-171.
65. Guo C, Xia Y, Niu P, Jiang L, Duan J, Yu Y, Zhou X, Li Y, Sun Z. Silica nanoparticles induce oxidative stress, inflammation, and endothelial dysfunction in vitro via activation of the MAPK/Nrf2 pathway and nuclear factor-κB signaling. Int J Nanomedicine 2015, 10:1463-1477.
66. Novotna B, Jendelova P, Kapcalova M, Rossner P Jr, Turnovcova K, Bagryantseva Y, Babic M, Horak D, Sykova E. Oxidative damage to biological macromolecules in human bone marrow mesenchymal stromal cells labeled with various types of iron oxide nanoparticles. Toxicol Lett 2012, 210:53-63.
67. Deng ZJ, Liang M, Monteiro M, Toth I, Minchin RF. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol 2011, 6:39-44.
68. Mahmoudi M, Shokrgozar MA, Sardari S, Moghadam MK, Vali H, Laurent S, Stroeve P. Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. Nanoscale 2011, 3:1127-1138.
69. Haase A, Arlinghaus HF, Tentschert J, Jungnickel H, Graf P, Mantion A, Draude F, Galla S, Plendl J, Goetz ME, et al. Application of laser postionization secondary neutral mass spectrometry/time-of-flight secondary ion mass spectrometry in nanotoxicology: visualization of nanosilver in human macrophages and cellular responses. ACS Nano 2011, 5:3059-3068.
70. Piao MJ, Kang KA, Lee IK, Kim HS, Kim S, Choi JY, Choi J, Hyun JW. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 2011, 201:92-100.
71. Scharf A, Piechulek A, von Mikecz A. Effect of nanoparticles on the biochemical and behavioral aging phenotype of the nematode Caenorhabditis elegans. ACS Nano 2013, 7:10695-10703.
72. Chen BPC, Li M, Asaithamby A. New insights into the roles of ATM and DNA-PKcs in the cellular response to oxidative stress. Cancer Lett 2012, 327:103-110.
73. Li JJ, Zou L, Hartono D, Ong CN, Bay BH, Lanry Yung LY. Gold nanoparticles induce oxidative damage in lung fibroblasts in vitro. Adv Mater 2008, 20:138-142.
74. Rinna A, Magdolenova Z, Hudecova A, Kruszewski M, Refsnes M, Dusinska M. Effect of silver nanoparticles on mitogen-activated protein kinases activation: role of reactive oxygen species and implication in DNA damage. Mutagenesis 2015, 30:59-66.
75. Gambino V, De Michele G, Venezia O, Migliaccio P, Dall'Olio V, Bernard L, Minardi SP, Della Fazia MA, Bartoli D, Servillo G, et al. Oxidative stress activates a specific p53 transcriptional response that regulates cellular senescence and aging. Aging Cell 2013, 12:435-445.
76. Setyawati MI, Tay CY, Leong DT. Effect of zinc oxide nanomaterials-induced oxidative stress on the p53 pathway. Biomaterials 2013, 34:10133-10142.
77. Chattopadhyay S, Dash SK, Tripathy S, Das B, Kar Mahapatra S, Pramanik P, Roy S. Cobalt oxide nanoparticles induced oxidative stress linked to activation of TNF-α/caspase-8/p38-MAPK signaling in human leukemia cells. J Appl Toxicol 2015, 35:603-613.
78. Shi J, Sun X, Lin Y, Zou X, Li Z, Liao Y, Du M, Zhang H. Endothelial cell injury and dysfunction induced by silver nanoparticles through oxidative stress via IKK/NF-κB pathways. Biomaterials 2014, 35:6657-6666.
79. Murray AR, Kisin E, Inman A, Young SH, Muhammed M, Burks T, Uheida A, Tkach A, Waltz M, Castranova V, et al. Oxidative stress and dermal toxicity of iron oxide nanoparticles in vitro. Cell Biochem Biophys 2013, 67:461-476.
80. Spigoni V, Cito M, Alinovi R, Pinelli S, Passeri G, Zavaroni I, Goldoni M, Campanini M, Aliatis I, Mutti A, et al. Effects of TiO(2) and Co(3)O(4) nanoparticles on circulating angiogenic cells. PLoS One 2015, 10:e0119310.
81. Wang J, Deng X, Zhang F, Chen D, Ding W. ZnO nanoparticle-induced oxidative stress triggers apoptosis by activating JNK signaling pathway in cultured primary astrocytes. Nanoscale Res Lett 2014, 9:117.
82. Pujalte I, Passagne I, Daculsi R, de Portal C, Ohayon-Courtes C, L'Azou B. Cytotoxic effects and cellular oxidative mechanisms of metallic nanoparticles on renal tubular cells: impact of particle solubility. Toxicol Res 2015, 4:409-422.
83. Ng KW, Khoo SP, Heng BC, Setyawati MI, Tan EC, Zhao X, Xiong S, Fang W, Leong DT, Loo JS. The role of the tumor suppressor p53 pathway in the cellular DNA damage response to zinc oxide nanoparticles. Biomaterials 2011, 32:8218-8225.
84. Setyawati MI, Yuan X, Xie J, Leong DT. The influence of lysosomal stability of silver nanomaterials on their toxicity to human cells. Biomaterials 2014, 35:6707-6715.
85. Ma X, Wu Y, Jin S, Tian Y, Zhang X, Zhao Y, Yu L, Liang X-J. Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment. ACS Nano 2011, 5:8629-8639.
86. Li JJ, Hartono D, Ong CN, Bay BH, Yung LY. Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials 2010, 31:5996-6003.
87. He Z, Liu J, Du L. The unexpected effect of PEGylated gold nanoparticles on the primary function of erythrocytes. Nanoscale 2014, 6:9017-9024.
88. Donaldson K, Poland CA. Inhaled nanoparticles and lung cancer-what we can learn from conventional particle toxicology. Swiss Med Wkly 2012, 142:w13547.
89. Magaye R, Zhou Q, Bowman L, Zou B, Mao G, Xu J, Castranova V, Zhao J, Ding M. Metallic nickel nanoparticles may exhibit higher carcinogenic potential than fine particles in JB6 cells. PLoS One 2014, 9:e92418.
90. Onuma K, Sato Y, Ogawara S, Shirasawa N, Kobayashi M, Yoshitake J, Yoshimura T, Iigo M, Fujii J, Okada F. Nano-scaled particles of titanium dioxide convert benign mouse fibrosarcoma cells into aggressive tumor cells. Am J Pathol 2009, 175:2171-2183.
91. Nemmar A, Albarwani S, Beegam S, Yuvaraju P, Yasin J, Attoub S, Ali BH. Amorphous silica nanoparticles impair vascular homeostasis and induce systemic inflammation. Int J Nanomedicine 2014, 9:2779-2789.
92. Huang C-L, Hsiao IL, Lin H-C, Wang C-F, Huang Y-J, Chuang C-Y. Silver nanoparticles affect on gene expression of inflammatory and neurodegenerative responses in mouse brain neural cells. Environ Res 2015, 136:253-263.
93. Wu J, Ding T, Sun J. Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum and hippocampus. Neurotoxicology 2013, 34:243-253.
94. Chen X, Zhouhua W, Jie Z, Xinlu F, Jinqiang L, Yuwen Q, Zhiying H. Renal interstitial fibrosis induced by high-dose mesoporous silica nanoparticles via the NF-κB signaling pathway. Int J Nanomedicine 2015, 10:1-22.
95. Keenan CR, Goth-Goldstein R, Lucas D, Sedlak DL. Oxidative stress induced by zero-valent iron nanoparticles and Fe(II) in human bronchial epithelial cells. Environ Sci Technol 2009, 43:4555-4560.
96. Bonner JC. Lung fibrotic responses to particle exposure. Toxicol Pathol 2007, 35:148-153.
97. Kawai K, Li Y-S, Kawasaki Y, Morimoto Y. Oxidative stress in rat lung after exposure to titanium dioxide and nickel oxide nanoparticles. Eur Respir J 2014, 44:4785.
98. Liu X, Sun J. Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-κB pathways. Biomaterials 2010, 31:8198-8209.
99. Bulcke F, Thiel K, Dringen R. Uptake and toxicity of copper oxide nanoparticles in cultured primary brain astrocytes. Nanotoxicology 2014, 8:775-785.
100. Golbamaki N, Rasulev B, Cassano A, Marchese Robinson RL, Benfenati E, Leszczynski J, Cronin MTD. Genotoxicity of metal oxide nanomaterials: review of recent data and discussion of possible mechanisms. Nanoscale 2015, 7:2154-2198.
101. Xie H, Mason MM, Wise JP Sr. Genotoxicity of metal nanoparticles. Rev Environ Health 2011, 26:251-268.
102. Li JJ, Lo SL, Ng CT, Gurung RL, Hartono D, Hande MP, Ong CN, Bay BH, Yung LY. Genomic instability of gold nanoparticle treated human lung fibroblast cells. Biomaterials 2011, 32:5515-5523.
103. Ng CT, Li JJ, Gurung RL, Hande MP, Ong CN, Bay BH, Yung LY. Toxicological profile of small airway epithelial cells exposed to gold nanoparticles. Exp Biol Med (Maywood) 2013, 238:1355-1361.
104. Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002, 192:1-15.
105. Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-κ B transcription factor. Mol Cell Biol 1990, 10:2327-2334.
106. Tay CY, Setyawati MI, Xie J, Parak WJ, Leong DT. Back to basics: exploiting the innate physico-chemical characteristics of nanomaterials for biomedical applications. Adv Funct Mater 2014, 24:5936-5955.
107. Leong DT, Ng KW. Probing the relevance of 3D cancer models in nanomedicine research. Adv Drug Deliv Rev 2014, 79-80:95-106.
108. Chia SL, Tay CY, Setyawati MI, Leong DT. Biomimicry 3D gastrointestinal spheroid platform for the assessment of toxicity and inflammatory effects of zinc oxide nanoparticles. Small 2015, 11:702-712.
109. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247.
110. Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H, Lleonart ME. Oxidative stress and cancer: an overview. Ageing Res Rev 2013, 12:376-390.
111. Li H, Horke S, Förstermann U. Oxidative stress in vascular disease and its pharmacological prevention. Trends Pharmacol Sci 2013, 34:313-319.
112. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
113. Singh DK, Winocour P, Farrington K. Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol 2011, 7:176-184.
114. Khanna P, Ong C, Bay B, Baeg G. Nanotoxicity: an interplay of oxidative stress. Inflamm Cell Death Nanomater 2015, 5:1163.
115. Liu D, Xu Y. p53, oxidative stress, and aging. Antioxid Redox Signal 2011, 15:1669-1678.
116. Kruidenier L, Kuiper I, van Duijn W, Marklund SL, van Hogezand RA, Lamers CB, Verspaget HW. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease. J Pathol 2003, 201:7-16.
117. Fenton HJH. LXXIII.-Oxidation of tartaric acid in presence of iron. J Chem Soc Trans 1894, 65:899-910.
118. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973, 179:588-590.
119. Marí M, Morales A, Colell A, García-Ruiz C, Fernández-Checa JC. Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal 2009, 11:2685-2700.
120. Campanella A, Rovelli E, Santambrogio P, Cozzi A, Taroni F, Levi S. Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia. Hum Mol Genet 2009, 18:1-11.
121. Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr 2002, 22:439-458.
122. Osaki S, Johnson DA, Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem 1966, 241:2746-2751.
123. Frei B. Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med 1994, 97:S5-S13.
124. Burton G, Ingold K. β-Carotene: an unusual type of lipid antioxidant. Science 1984, 224:569-573.
125. Retsky KL, Freeman MW, Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions. J Biol Chem 1993, 268:1304-1309.
126. Packer JE, Slater TF, Willson RL. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979, 278:737-738.
127. Burton GW, Wronska U, Stone L, Foster DO, Ingold KU. Biokinetics of dietary RRR-α-tocopherol in the male guinea pig at three dietary levels of vitamin C and two levels of vitamin E. Evidence that vitamin C does not 'spare' vitamin E in vivo. Lipids 1990, 25:199-210.
128. Mattson MP. Hormesis defined. Ageing Res Rev 2008, 7:1-7.
129. Jiao Z-H, Li M, Feng Y-X, Shi J-C, Zhang J, Shao B. Hormesis effects of silver nanoparticles at non-cytotoxic doses to human hepatoma cells. PLoS One 2014, 9:e102564.
130. Yin H, Casey PS, McCall MJ. Surface modifications of ZnO nanoparticles and their cytotoxicity. J Nanosci Nanotechnol 2010, 10:7565-7570.
131. Iavicoli I, Calabrese EJ, Nascarella MA. Exposure to nanoparticles and hormesis. Dose Response 2010, 8:501-517.
132. Iavicoli I, Fontana L, Leso V, Calabrese EJ. Hormetic dose-responses in nanotechnology studies. Sci Total Environ 2014, 487:361-374.
133. Sanvicens N, Marco MP. Multifunctional nanoparticles-properties and prospects for their use in human medicine. Trends Biotechnol 2008, 26:425-433.
134. Pati R, Mehta RK, Mohanty S, Padhi A, Sengupta M, Vaseeharan B, Goswami C, Sonawane A. Topical application of zinc oxide nanoparticles reduces bacterial skin infection in mice and exhibits antibacterial activity by inducing oxidative stress response and cell membrane disintegration in macrophages. Nanomed: Nanotechnol Biol Med 2014, 10:1195-1208.
135. Nair S, Sasidharan A, Divya Rani VV, Menon D, Nair S, Manzoor K, Raina S. Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. J Mater Sci Mater Med 2009, 20:235-241.
136. Wahab R, Siddiqui MA, Saquib Q, Dwivedi S, Ahmad J, Musarrat J, Al-Khedhairy AA, Shin H-S. ZnO nanoparticles induced oxidative stress and apoptosis in HepG2 and MCF-7 cancer cells and their antibacterial activity. Colloids Surf B Biointerfaces 2014, 117:267-276.
137. Wahab R, Dwivedi S, Umar A, Singh S, Hwang IH, Shin HS, Musarrat J, Al-Khedhairy AA, Kim YS. ZnO nanoparticles induce oxidative stress in Cloudman S91 melanoma cancer cells. J Biomed Nanotechnol 2013, 9:441-449.
138. Sadhukha T, Wiedmann TS, Panyam J. Enhancing therapeutic efficacy through designed aggregation of nanoparticles. Biomaterials 2014, 35:7860-7869.
139. Guo D, Zhang J, Huang Z, Jiang S, Gu N. Colloidal silver nanoparticles improve anti-leukemic drug efficacy via amplification of oxidative stress. Colloids Surf B Biointerfaces 2015, 126:198-203.
140. Sack M, Alili L, Karaman E, Das S, Gupta A, Seal S, Brenneisen P. Combination of conventional chemotherapeutics with redox-active cerium oxide nanoparticles-a novel aspect in cancer therapy. Mol Cancer Ther 2014, 13:1740-1749.
141. Huang G, Chen H, Dong Y, Luo X, Yu H, Moore Z, Bey EA, Boothman DA, Gao J. Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy. Theranostics 2013, 3:116-126.
142. Klein S, Sommer A, Distel LVR, Hazemann J-L, Kröner W, Neuhuber W, Müller P, Proux O, Kryschi C. Superparamagnetic iron oxide nanoparticles as novel X-ray enhancer for low-dose radiation therapy. J Phys Chem B 2014, 118:6159-6166.
143. Lu H-Y, Chang Y-J, Fan N-C, Wang L-S, Lai N-C, Yang C-M, Wu L-C, Ho J-A. Synergism through combination of chemotherapy and oxidative stress-induced autophagy in A549 lung cancer cells using redox-responsive nanohybrids: a new strategy for cancer therapy. Biomaterials 2015, 42:30-41.
144. Ismail AFM, Ali MM, Ismail LFM. Photodynamic therapy mediated antiproliferative activity of some metal-doped ZnO nanoparticles in human liver adenocarcinoma HepG2 cells under UV irradiation. J Photochem Photobiol B: Biol 2014, 138:99-108.
145. Farcal L, Torres Andon F, Di Cristo L, Rotoli BM, Bussolati O, Bergamaschi E, Mech A, Hartmann NB, Rasmussen K, Riego-Sintes J, et al. Comprehensive in vitro toxicity testing of a panel of representative oxide nanomaterials: first steps towards an intelligent testing strategy. PLoS One 2015, 10:e0127174.
146. Dikalov SI, Harrison DG. Methods for detection of mitochondrial and cellular reactive oxygen species. Antioxid Redox Signal 2014, 20:372-382.
147. Zielonka J, Srinivasan S, Hardy M, Ouari O, Lopez M, Vasquez-Vivar J, Avadhani NG, Kalyanaraman B. Cytochrome c-mediated oxidation of hydroethidine and mito-hydroethidine in mitochondria: identification of homo- and heterodimers. Free Radic Biol Med 2008, 44:835-846.
148. Dikalov S, Skatchkov M, Fink B, Bassenge E. Quantification of superoxide radicals and peroxynitrite in vascular cells using oxidation of sterically hindered hydroxylamines and electron spin resonance. Nitric Oxide 1997, 1:423-431.
149. Zhou M, Diwu Z, Panchuk-Voloshina N, Haugland RP. A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal Biochem 1997, 253:162-168.
150. Biondi R, Xia Y, Rossi R, Paolocci N, Ambrosio G, Zweier JL. Detection of hydroxyl radicals by D-phenylalanine hydroxylation: a specific assay for hydroxyl radical generation in biological systems. Anal Biochem 2001, 290:138-145.
151. Kooy NW, Royall JA, Ischiropoulos H, Beckman JS. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic Biol Med 1994, 16:149-156.
152. Possel H, Noack H, Augustin W, Keilhoff G, Wolf G. 2, 7-Dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite formation. FEBS Lett 1997, 416:175-178.
153. Sikora A, Zielonka J, Lopez M, Dybala-Defratyka A, Joseph J, Marcinek A, Kalyanaraman B. Reaction between peroxynitrite and boronates: EPR spin-trapping, HPLC analyses, and quantum mechanical study of the free radical pathway. Chem Res Toxicol 2011, 24:687-697.
154. Shigenaga MK, Gimeno CJ, Ames BN. Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci 1989, 86:9697-9701.
155. Azqueta A, Collins A. The essential comet assay: a comprehensive guide to measuring DNA damage and repair. Arch Toxicol 2013, 87:949-968.
156. Collins AR. Measuring oxidative damage to DNA and its repair with the comet assay. Biochim Biophys Acta 2014, 1840:794-800.
157. Fenech M. Cytokinesis-block micronucleus cytome assay. Nat Protoc 2007, 2:1084-1104.
158. Xiao GG, Nel AE, Loo JA. Nitrotyrosine-modified proteins and oxidative stress induced by diesel exhaust particles. Electrophoresis 2005, 26:280-292.
159. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003, 329:23-38.
160. Mandavilli BS, Aggeler R. Abstract 512: Cell-based analysis of oxidative stress, lipid peroxidation and lipid peroxidation-derived protein modifications using fluorescence microscopy. Cancer Res 2014, 74:512.
161. Dawn-Linsley M, Ekinci FJ, Ortiz D, Rogers E, Shea TB. Monitoring thiobarbituric acid-reactive substances (TBARs) as an assay for oxidative damage in neuronal cultures and central nervous system. J Neurosci Methods 2005, 141:219-222.
162. Mateos R, Lecumberri E, Ramos S, Goya L, Bravo L. Determination of malondialdehyde (MDA) by high-performance liquid chromatography in serum and liver as a biomarker for oxidative stress: application to a rat model for hypercholesterolemia and evaluation of the effect of diets rich in phenolic antioxidants from fruits. J Chromatogr B 2005, 827:76-82.
163. Milne GL, Sanchez SC, Musiek ES, Morrow JD. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc 2007, 2:221-226.
164. Weydert CJ, Cullen JJ. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat Protoc 2010, 5:51-66.
165. Kazarjan J, Vaher M, Hunter T, Kulp M, Hunter GJ, Bonetta R, Farrugia D, Kaljurand M. Determination of metal content in superoxide dismutase enzymes by capillary electrophoresis†. J Sep Sci 2015, 38:1042-1045.
166. Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 1989, 179:8-18.
167. Beers RF Jr, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 1952, 195:133-140.
168. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158-169.
169. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 1976, 71:952-958.
170. Ganini D, Canistro D, Jiang J, Stadler K, Mason RP, Kadiiska MB. Ceruloplasmin (ferroxidase) oxidizes hydroxylamine probes: deceptive implications for free radical detection. Free Radic Biol Med 2012, 53:1514-1521.
171. Hirowatari Y, Yoshida H, Kurosawa H, Manita D, Tada N. Automated measurement method for the determination of vitamin E in plasma lipoprotein classes. Sci Rep 2014, 4:4086.
172. Kamencic H, Lyon A, Paterson PG, Juurlink BH. Monochlorobimane fluorometric method to measure tissue glutathione. Anal Biochem 2000, 286:35-37.
173. Hedley DW, Chow S. Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 1994, 15:349-358.
174. Zhao H, Kalivendi S, Zhang H, Joseph J, Nithipatikom K, Vasquez-Vivar J, Kalyanaraman B. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic Biol Med 2003, 34:1359-1368.
175. Anreddy R, Yellu N, Devarakonda K. Oxidative biomarkers to assess the nanoparticle-induced oxidative stress. In: Armstrong D, Bharali DJ, eds. Oxidative Stress and Nanotechnology, vol. 1028. New York: Humana Press; 2013, 205-219.
176. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. In: Lester Packer ANG, ed. Methods in Enzymology, vol. 186. San Diego: Academic Press; 1990, 421-431.
177. Kasapoglu M, Özben T. Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp Gerontol 2001, 36:209-220.